Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Singapore Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20073
20085
20093
20104
20116
20125
20132
20142
20153
20162
20176
20184
20197
20202
20213
20223
20233
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
National University of Singapore7
Singapore Institute of Food and Biotechnology Innovation7
Novo Nordisk A/S6
Novartis Pharmaceuticals4
Singapore General Hospital4
Bayer3
Duke-NUS Graduate Medical School3
AstraZeneca2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 269
Diabetes Mellitus18
Obesity6
Glucose Intolerance3
Diabetes Mellitus, Type 12
Diabetic Foot2
Diabetic Nephropathies2
Hyperglycemia2
Kidney Diseases2
Metabolic Diseases2

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.